UNSPSC 85582645: Fragmentation in left parotid duct, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to fragmentation in left parotid duct, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0CFC3ZZ

UNSPSC 85582645 Fragmentation in left parotid duct, percutaneous approach is a Commodity code that shows no relevant recent activity in state and local procurement. The code nominally describes a clinical procedure for treatment of salivary gland obstruction, yet the recent opportunities posted under this code encompass inmate medical and pharmacy services, pharmacy benefit management, virtual primary and urgent care services, peer support for peer workers, and fire department medical director services — none of which directly align with parotid duct fragmentation or percutaneous surgical intervention. This mismatch suggests either a data classification error in how opportunities were tagged to the code or that the code itself is misapplied to the state and local procurement taxonomy.

The five recent solicitations originate from four state and local jurisdictions: Muscogee County (Georgia), Collier County (Florida), Monroe County (Florida), San Mateo County (California), and the Santa Monica Fire Department (California). The opportunities span correctional healthcare contracting, employee pharmacy benefits administration, virtual care delivery, behavioral health peer support pilots, and EMS medical direction — none of which fall within the clinical specialty the UNSPSC code describes. Response dates range from July 2, 2025 (San Mateo County MHSA peer support pilot) through May 15, 2026 (Muscogee County inmate medical services). Without evidence that state and local governments are actually procuring parotid duct procedures or related percutaneous otolaryngological services under this code, the category does not present a viable pursuit opportunity for firms specializing in that clinical area. The tagging discrepancy warrants clarification with procurement offices before developing business development strategy around this code.